NORDIC BIOTECH HOLDING ApS: Financial statements 2022
CVR: 26409683
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NORDIC BIOTECH HOLDING ApS (CVR 26409683) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 113,606 and a net result of DKK 95,776 compared with DKK 305,283 the year before. That is a decrease of 65% compared with the year before. Equity in the 2022 report amounted to DKK 853,699. The solvency ratio was 77.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 113,606
- Profit/Loss
- DKK 95,776
- Equity
- DKK 853,699
- Total Assets
- DKK 1,106,995
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 114K | 96K | 854K | 1 |
| 2021 | - | 325K | 305K | 758K | 1 |
| 2020 | - | 442K | 325K | -462K | 1 |
| 2019 | - | -697K | -688K | -788K | - |
| 2018 | - | -169K | -292K | -100K | - |
Official annual report
Keep an eye on NORDIC BIOTECH HOLDING ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NORDIC BIOTECH HOLDING ApS has published its annual report for 2021. Gross profit came to DKK 324,716, and the net result was DKK 305,283.
About NORDIC BIOTECH HOLDING ApS
NORDIC BIOTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SN BIOTECH HOLDING ApS. The management consists of Torsten Bjørn. The company is owned by FINANSMANAGEMENT ApS. The company has 1 employee (2012). In 2025, the company reported a gross profit of DKK -39,555 and a net result of DKK -7,860 compared with DKK -39,278 the year before. Equity in the 2025 report amounted to DKK 139,260.
